SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001213900-24-040489
Filing Date
2024-05-07
Accepted
2024-05-07 16:30:17
Documents
13
Period of Report
2024-05-02
Items
Item 3.01: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing
Item 8.01: Other Events

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT ea0205420-8k_avalon.htm   iXBRL 8-K 30617
  Complete submission text file 0001213900-24-040489.txt   208014

Data Files

Seq Description Document Type Size
2 XBRL SCHEMA FILE albt-20240502.xsd EX-101.SCH 3039
3 XBRL LABEL FILE albt-20240502_lab.xml EX-101.LAB 34240
4 XBRL PRESENTATION FILE albt-20240502_pre.xml EX-101.PRE 22375
16 EXTRACTED XBRL INSTANCE DOCUMENT ea0205420-8k_avalon_htm.xml XML 3798
Mailing Address 4400 ROUTE 9 SUITE 3100 FREEHOLD NJ 07728
Business Address 4400 ROUTE 9 SUITE 3100 FREEHOLD NJ 07728 732-780-4400
Avalon GloboCare Corp. (Filer) CIK: 0001630212 (see all company filings)

IRS No.: 471685128 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38728 | Film No.: 24922461
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)